검색
Zoetis Inc
ZTS관심 목록에 추가
76.280USD
-0.390-0.51%
시장 운영 시간 （ET）시세는 15분 지연됩니다
32.06B시가총액
12.63P/E TTM
자세한 내용은 Zoetis Inc 회사
Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
Zoetis Inc 정보
종목 코드 ZTS
회사 이름Zoetis Inc
상장일Feb 01, 2013
CEOPeck (Kristin C)
직원 수13800
유형Ordinary Share
회계 연도 종료Feb 01
주소10 Sylvan Way
도시PARSIPPANY
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United States of America
우편 번호07054
전화19738227000
웹사이트https://www.zoetis.com/
종목 코드 ZTS
상장일Feb 01, 2013
CEOPeck (Kristin C)
Zoetis Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
105.90K
+0.02%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
18.17K
--
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
16.26K
--
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--
Ms. Rimma Driscoll
Ms. Rimma Driscoll
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
5.71K
+9.15%
Ms. Vanessa Broadhurst
Ms. Vanessa Broadhurst
Independent Director
Independent Director
3.92K
--
Mr. Jamie Brannan
Mr. Jamie Brannan
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
3.73K
+0.72%
Mr. Keith Sarbaugh
Mr. Keith Sarbaugh
Executive Vice President, Chief Digital and Technology Officer
Executive Vice President, Chief Digital and Technology Officer
3.35K
+30.01%
Dr. Robert J. (Rob) Polzer, Ph.D.
Dr. Robert J. (Rob) Polzer, Ph.D.
Executive Vice President, President - Research and Development
Executive Vice President, President - Research and Development
1.96K
-216.45%
Mr. Nicholas (Nick) Ashton
Mr. Nicholas (Nick) Ashton
Executive Vice President, President - Global Manufacturing and Supply
Executive Vice President, President - Global Manufacturing and Supply
1.82K
+39.96%
더 보기
이름
이름/직위
직위
주식 보유
변동
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
105.90K
+0.02%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
18.17K
--
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
16.26K
--
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--
Ms. Rimma Driscoll
Ms. Rimma Driscoll
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
5.71K
+9.15%
Ms. Vanessa Broadhurst
Ms. Vanessa Broadhurst
Independent Director
Independent Director
3.92K
--
수익 분석
통화: USD마지막 업데이트: Mon, Apr 6
통화: USD마지막 업데이트: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Parasiticides
2.34B
24.73%
Vaccines
1.96B
20.69%
Dermatology
1.75B
18.53%
Anti-infectives
1.04B
10.94%
Pain and sedation
840.00M
8.87%
기타
1.54B
16.24%
지역별USD
이름
수익
비율
United States
5.10B
53.84%
Other emerging markets
913.00M
9.64%
Other Developed
641.00M
6.77%
Brazil
393.00M
4.15%
Australia
329.00M
3.48%
기타
2.09B
22.12%
사업별
지역별
사업별USD
이름
수익
비율
Parasiticides
2.34B
24.73%
Vaccines
1.96B
20.69%
Dermatology
1.75B
18.53%
Anti-infectives
1.04B
10.94%
Pain and sedation
840.00M
8.87%
기타
1.54B
16.24%
주식 보유 통계
마지막 업데이트: Mon, May 11
마지막 업데이트: Mon, May 11
주주
주주 유형
주주
주주
비율
Vanguard Capital Management, LLC
6.22%
Vanguard Portfolio Management, LLC
5.72%
BlackRock Institutional Trust Company, N.A.
5.67%
State Street Investment Management (US)
4.72%
State Farm Insurance Companies
4.03%
기타
73.64%
주주
주주
비율
Vanguard Capital Management, LLC
6.22%
Vanguard Portfolio Management, LLC
5.72%
BlackRock Institutional Trust Company, N.A.
5.67%
State Street Investment Management (US)
4.72%
State Farm Insurance Companies
4.03%
기타
73.64%
주주 유형
주주
비율
Investment Advisor
52.32%
Investment Advisor/Hedge Fund
33.37%
Research Firm
4.22%
Insurance Company
4.11%
Pension Fund
2.87%
Bank and Trust
2.61%
Hedge Fund
1.45%
Sovereign Wealth Fund
1.44%
Individual Investor
0.08%
기관 주식 보유
마지막 업데이트: Wed, Apr 1
마지막 업데이트: Wed, Apr 1
보고 기간
기관 수
보유 주식
비율
변동
2026Q4
2795
428.61M
99.51%
--
2026Q1
3406
423.47M
101.00%
-18.24M
2025Q4
3335
436.13M
98.96%
-14.08M
2025Q3
3275
435.62M
98.29%
-1.39M
2025Q2
3277
434.35M
98.00%
-1.58M
2025Q1
3284
432.42M
97.12%
-4.21M
2024Q4
3199
430.60M
96.14%
-9.58M
2024Q3
3090
434.14M
95.81%
-13.19M
2024Q2
3062
437.75M
95.94%
-9.33M
2024Q1
3060
439.45M
96.16%
-2.63M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
BlackRock Institutional Trust Company, N.A.
23.78M
5.63%
+982.47K
+4.31%
Dec 31, 2025
State Street Investment Management (US)
19.80M
4.69%
+149.38K
+0.76%
Dec 31, 2025
State Farm Insurance Companies
16.88M
4%
+9.70K
+0.06%
Dec 31, 2025
Wellington Management Company, LLP
11.39M
2.7%
+2.85M
+33.41%
Dec 31, 2025
Geode Capital Management, L.L.C.
11.33M
2.68%
+189.24K
+1.70%
Dec 31, 2025
Morgan Stanley Investment Management Ltd. (UK)
6.65M
1.58%
-827.17K
-11.06%
Dec 31, 2025
Norges Bank Investment Management (NBIM)
5.84M
1.38%
+646.40K
+12.45%
Dec 31, 2025
Polen Capital Management, LLC
5.56M
1.32%
-1.95M
-26.00%
Dec 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
ProShares Pet Care ETF
9.4%
VanEck Pharmaceutical ETF
9.02%
VanEck Agribusiness ETF
7.81%
iShares U.S. Pharmaceuticals ETF
4.26%
Honeytree US Equity ETF
3.86%
First Trust NASDAQ Pharmaceuticals ETF
3.58%
Polen Capital Global Growth ETF
3.35%
State Street SPDR S&P Pharmaceuticals ETF
2.51%
AAM Sawgrass US Large Cap Quality Growth ETF
2.47%
Themes US R&D Champions ETF
1.96%
더 보기
ProShares Pet Care ETF
비율9.4%
VanEck Pharmaceutical ETF
비율9.02%
VanEck Agribusiness ETF
비율7.81%
iShares U.S. Pharmaceuticals ETF
비율4.26%
Honeytree US Equity ETF
비율3.86%
First Trust NASDAQ Pharmaceuticals ETF
비율3.58%
Polen Capital Global Growth ETF
비율3.35%
State Street SPDR S&P Pharmaceuticals ETF
비율2.51%
AAM Sawgrass US Large Cap Quality Growth ETF
비율2.47%
Themes US R&D Champions ETF
비율1.96%
주식 배당금
지난 5년 동안 총
2.56B
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Feb 05, 2026
ZTS.NB Interim Cash Dividend of gross USD 0.53 paid on Jun 02, 2026 going ex on Apr 20, 2026
Apr 20, 2026
Jun 02, 2026
Apr 20, 2026
Dec 11, 2025
ZTS.NB Interim Cash Dividend of gross USD 0.53 paid on Mar 03, 2026 going ex on Jan 20, 2026
Jan 20, 2026
Mar 03, 2026
Jan 20, 2026
Oct 09, 2025
ZTS.NB Final Cash Dividend of gross USD 0.5 paid on Dec 02, 2025 going ex on Oct 31, 2025
Oct 31, 2025
Dec 02, 2025
Oct 31, 2025
May 21, 2025
ZTS.NB Interim Cash Dividend of gross USD 0.5 paid on Sep 03, 2025 going ex on Jul 18, 2025
Jul 18, 2025
Sep 03, 2025
Jul 18, 2025
Feb 06, 2025
ZTS.NB Interim Cash Dividend of gross USD 0.5 paid on Jun 03, 2025 going ex on Apr 21, 2025
Apr 21, 2025
Jun 03, 2025
Apr 21, 2025
Dec 12, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.5 paid on Mar 04, 2025 going ex on Jan 21, 2025
Jan 21, 2025
Mar 04, 2025
Jan 21, 2025
Oct 10, 2024
ZTS.NB Final Cash Dividend of gross USD 0.432 paid on Dec 03, 2024 going ex on Oct 31, 2024
Oct 31, 2024
Dec 03, 2024
Oct 31, 2024
May 22, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Sep 04, 2024 going ex on Jul 18, 2024
Jul 18, 2024
Sep 04, 2024
Jul 18, 2024
Feb 06, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Jun 04, 2024 going ex on Apr 18, 2024
Apr 19, 2024
Jun 04, 2024
Apr 18, 2024
Dec 07, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Mar 01, 2024 going ex on Jan 18, 2024
Jan 19, 2024
Mar 01, 2024
Jan 18, 2024
더 보기
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
